SCARB1 and atherosclerosis: found that TT upregulated the expression of scavenger receptor B1 (SR-B1) in HepG2 hepatocytes, leading to a decrease in HDL-C levels, and induced the cholesterol efflux from macrophages and retrograde transport toward the liver, and thus concluded that TT could prevent atherosclerosis (47).